Figure S10 from Profiling the Activity of the Potent and Highly Selective CDK2 Inhibitor BLU-222 Reveals Determinants of Response in CCNE1-Aberrant Ovarian and Endometrial Tumors
Authors:
- Nealia C. HouseNHNealia C. House
- Victoria E. BrownVBVictoria E. Brown
- Maxine ChenMCMaxine Chen
- Liang YuanLYLiang Yuan
- Sydney L. MooreSMSydney L. Moore
- Jian GuoJGJian Guo
- Yoon Jong ChoiYCYoon Jong Choi
- Lakshmi MuthuswamyLMLakshmi Muthuswamy
- Scott RibichSRScott Ribich
- Philip RamsdenPRPhilip Ramsden
- Kerrie L. FaiaKFKerrie L. Faia
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)